SSH - PENSACOLA INC — History
CCN 102024 | 3-year financial timeline | COVID resilience: 28/100
🛡️ Public data only — no PHI permitted on this instance.
$32M
Latest Revenue (FY2022)
-3.9%
Revenue CAGR (3yr)
-17.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $35M | $35M | $32M | -9.2% | -3.9% |
| Operating Expenses | $32M | $33M | $37M | +15.1% | +8.3% |
| Operating Margin | 7.5% | 7.3% | -17.4% | -337.6% | +0.0% |
| Net Income | $3M | $3M | $-6M | -315.8% | +0.0% |
| Licensed Beds | 75 | 75 | 75 | +0.0% | +0.0% |
| Total Patient Days | 22,950 | 23,140 | 21,234 | -8.2% | -3.8% |
| Medicare Day % | 57% | 55% | 45% | -17.4% | -10.9% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 28/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -7.7% ($35M → $32M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-3.9%
This Hospital
+7.6%
State Avg
Latest Margin
-17.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $31M | -29.8% |
| FY2024 (proj) | $29M | -42.3% |
| FY2025 (proj) | $28M | -54.7% |